Living-Donor Lung Transplantation for Post-COVID-19 Respiratory Failure.
Ann Thorac Surg
; 114(1): e21-e24, 2022 07.
Article
in English
| MEDLINE | ID: covidwho-1499632
ABSTRACT
This report describes a case of coronavirus disease 2019 (COVID-19)-associated respiratory failure requiring urgent living-donor lobar lung transplantation (LDLLTx). Severe hypoxia requiring extracorporeal membrane oxygenation (ECMO) developed in a 57-year-old woman with positive viral status. Her respiratory function deteriorated, with almost totally collapsed lungs. All of her other organs functioned well. After 104 days of ECMO support, she underwent urgent LDLLTx using cardiopulmonary bypass. The grafts worked well, and she was weaned from cardiopulmonary bypass after reperfusion. LDLLTx is an option for selected patients with post-COVID-19 end-stage respiratory failure.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Respiratory Insufficiency
/
Extracorporeal Membrane Oxygenation
/
Lung Transplantation
/
COVID-19
Type of study:
Case report
Topics:
Long Covid
Limits:
Female
/
Humans
/
Middle aged
Language:
English
Journal:
Ann Thorac Surg
Year:
2022
Document Type:
Article
Affiliation country:
J.athoracsur.2021.10.003
Similar
MEDLINE
...
LILACS
LIS